Bojana Mirković

Bojana Mirković

Auto-generated profile, based on publicly available information

Bojana Mirković

Department of Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SCSanjay Haresh Chotirmall
Sanjay Haresh Chotirmall
MAMazen Al-Alawi
Mazen Al-Alawi
BMBojana Mirkovic
Bojana Mirkovic
GLGillian Lavelle
Gillian Lavelle
PLP. Mark Logan
P. Mark Logan
NMNoel G. McElvaney
Noel G. McElvaney
Aspergillusmoulds exist ubiquitously as spores that are inhaled in large numbers daily. Whilst most are removed by anatomical barriers, disease may occur in certain circumstances. Depending on the underlying state of the human immune system, clinical consequences can ensue ranging from an excessive immune response during allergic bronchopulmonary aspergillosis to the formation of an aspergilloma in the immunocompetent state. The severest infections occur in those who are immunocompromised where invasive pulmonary aspergillosis results in high mortality rates. The diagnosis ofAspergillus-associated pulmonary disease is based on clinical, radiological, and immunological testing. An understanding of the innate and inflammatory consequences of exposure toAspergillusspecies is critical in accounting for disease manifestations and preventing sequelae. The major components of the innate immune system involved in recognition and removal of the fungus include phagocytosis, antimicrobial peptide production, and recognition by pattern recognition receptors. The cytokine response is also critical facilitating cell-to-cell communication and promoting the initiation, maintenance, and resolution of the host response. In the following review, we discuss the above areas with a focus on the innate and inflammatory response to airwayAspergillusexposure and how these responses may be modulated for therapeutic benefit.

25 June 2018 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
MMMarianne S. Muhlebach
Marianne S. Muhlebach
JHJoseph E. Hatch
Joseph E. Hatch
GEGisli G. Einarsson
Gisli G. Einarsson
SMStef J. McGrath
Stef J. McGrath
DGDeirdre F. Gilipin
Deirdre F. Gilipin
MTMichael M. Tunney
Michael M. Tunney
Anaerobic and aerobic bacteria were quantitated in respiratory samples across three cystic fibrosis (CF) centres using extended culture methods. Subjects aged 1–69 years who were clinically stable provided sputum (n=200) or bronchoalveolar lavage (n=55). 18 anaerobic and 39 aerobic genera were cultured from 59% and 95% of samples, respectively; 16 out of 57 genera had a ≥5% prevalence across centres.Analyses of microbial communities using co-occurrence networks in sputum samples showed groupings of oral, including anaerobic, bacteria, whereas typical CF pathogens formed distinct entities.Pseudomonaswas associated with worse nutrition and F508del genotype, whereas anaerobe prevalence was positively associated with pancreatic sufficiency, better nutrition and better lung function. A higher total anaerobe/total aerobe CFU ratio was associated with pancreatic sufficiency and better nutrition. Subjects grouped by factor analysis who had relative dominance of anaerobes over aerobes had milder disease compared with aPseudomonas-dominated group with similar proportions of subjects that were homozygous for F508del.In summary, anaerobic bacteria occurred at an early age. In sputum-producing subjects anaerobic bacteria were associated with milder disease, suggesting that targeted eradication of anaerobes may not be warranted in sputum-producing CF subjects.

19 November 2015 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
YGYael Gernez
Yael Gernez
JWJeffrey Waters
Jeffrey Waters
BMBojana Mirković
Bojana Mirković
GLGillian M. Lavelle
Gillian M. Lavelle
CDColleen E. Dunn
Colleen E. Dunn
RMRichard B Moss
Richard B Moss
The diagnosis of cystic fibrosis (CF) patients with allergic bronchopulmonary aspergillosis (ABPA) is clinically challenging, due to the absence of an objective biological test. Since blood basophils play a major role in allergic responses, we hypothesised that changes in their surface activation pattern discriminate between CF patients with and without ABPA.We conducted a prospective longitudinal study (Stanford cohort) comparing basophil activation test CD203c levels by flow cytometry before and after activation withAspergillus fumigatusallergen extract or recombinantAspf1 in 20 CF patients with ABPA (CF-ABPA) and in two comparison groups: CF patients withA. fumigatuscolonisation (AC) but without ABPA (CF-AC; n=13) and CF patients without either AC or ABPA (CF; n=12). Patients were tested every 6 months and when ill with pulmonary exacerbation. We also conducted cross-sectional validation in a separate patient set (Dublin cohort).Basophil CD203c surface expression reliably discriminated CF-ABPA from CF-AC and CF over time. Ex vivostimulation withA. fumigatusextract or recombinantAspf1 produced similar results within the Stanford (p<0.0001) and the Dublin cohorts. CF-ABPA patients were likelier to have elevated specific IgE toA. fumigatusand were less frequently co-infected withStaphylococcus aureus.Basophil CD203c upregulation is a suitable diagnostic and stable monitoring biomarker of ABPA in CF.

1 December 2021 in Clinical Nutrition ESPEN
Verified
Journal Article
Open access
FGFlavia Genua
Flavia Genua
BMBojana Mirković
Bojana Mirković
AMAmy Mullee
Amy Mullee
MLMiroslav Levy
Miroslav Levy
WGWilliam M. Gallagher
William M. Gallagher
DHDavid J. Hughes
David J. Hughes
Short chain fatty acid (SCFAs) are bacterially derived metabolites suggested to have protective roles against colorectal cancer (CRC) development. However, there is sparse evidence from epidemiological studies in this context. Here, we assessed whether circulating SCFA concentrations varied in patients with colorectal adenomas (CRA) and CRC. Levels of seven SCFAs were extracted from plasma samples and determined by gas chromatography for 213 individuals from Ireland and the Czech Republic (CRC, n = 84; CRA, n = 66; controls, n = 63). In the Irish CRA/CRC cohort, only levels of 2-MethylButyric acid were significantly higher in cancers compared to the adenoma and control groups (p-values = 0.016 and 0.043). Using regression analysis, we observed that levels of Acetic and Propionic acid were associated with an increased CRC risk in the Czech cohort (Odd Ratio (OR): 1.02; 95% Confidence interval (CI): 1.00-1.03; OR: 1.29; 95% CI: 1.05-1.59, respectively), while i-Valeric and Valeric acid levels were associated with a decreased cancer risk (OR: 0.92; 95% CI: 0.86-0.99; OR: 0.67; 95% CI: 0.44-1.00). In the Irish cohort, levels of SCFAs were not associated with CRC risk. The association with colorectal neoplasia varied between the studied SCFAs. Future studies need to confirm these findings and address the mechanism of how these acids may promote or prevent colorectal carcinogenesis.

17 July 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
AMAna Mitrović
Ana Mitrović
ISIzidor Sosic
Izidor Sosic
ŠKŠpela Kos
Špela Kos
UTUrsa Lampreht Tratar
Ursa Lampreht Tratar
Barbara BreznikBarbara Breznik
Barbara Breznik
JKJanko Kos
Janko Kos
Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo Addition of 2-(ethylamino)acetonitrile group to nitroxoline results in significantly improved anti-tumor activity in vitro and in vivo

1 September 2011 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ISIzidor Sosic
Izidor Sosic
BMBojana Mirković
Bojana Mirković
STSamo Turk
Samo Turk
Bogdan ŠtefaneBogdan Štefane
Bogdan Štefane
JKJanko Kos
Janko Kos
SGStanislav Gobec
Stanislav Gobec